Benzoic acid

Identification

Summary

Benzoic acid is an antimicrobial food additive.

Brand Names
Ammonul, Hyophen
Generic Name
Benzoic acid
DrugBank Accession Number
DB03793
Background

A fungistatic compound that is widely used as a food preservative. It is conjugated to GLYCINE in the liver and excreted as hippuric acid. As the sodium salt form, sodium benzoate is used as a treatment for urea cycle disorders due to its ability to bind amino acids. This leads to excretion of these amino acids and a decrease in ammonia levels. Recent research shows that sodium benzoate may be beneficial as an add-on therapy (1 gram/day) in schizophrenia. Total Positive and Negative Syndrome Scale scores dropped by 21% compared to placebo.

Type
Small Molecule
Groups
Approved, Investigational
Structure
Weight
Average: 122.123
Monoisotopic: 122.036779433
Chemical Formula
C7H6O2
Synonyms
  • Benzoic acid
External IDs
  • E-210
  • FEMA NO. 2131
  • INS NO.210
  • INS-210
  • NSC-149

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Indication TypeIndicationCombined Product DetailsApproval LevelAge GroupPatient CharacteristicsDose Form
Used in combination to treatInfections, fungalCombination Product in combination with: Resorcinol (DB11085), Salicylic acid (DB00936)••••••••••••
Used in combination for symptomatic treatment ofOropharyngeal painCombination Product in combination with: Benzyl alcohol (DB06770)••• ••••••••••
Used in combination to treatPainCombination Product in combination with: Amylocaine (DB09088)••• ••••••••
Used in combination to treatRingwormCombination Product in combination with: Salicylic acid (DB00936)••• •••••••••
Used in combination to treatRingwormCombination Product in combination with: Salicylic acid (DB00936)••••••••••••••••••••
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
USolute carrier family 15 member 1Not AvailableHumans
UCocaine esterase
product of
Rhodococcus sp. (strain MB1 Bresler)
UD-amino-acid oxidaseNot AvailableHumans
UChlorocatechol 1,2-dioxygenase
substrate
Rhodococcus opacus
U2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolaseNot AvailablePseudomonas fluorescens
UNon-heme chloroperoxidaseNot AvailableStreptomyces aureofaciens
UOxygen-insensitive NAD(P)H nitroreductaseNot AvailableEnterobacter cloacae
UHydroxyquinol 1,2-dioxygenaseNot AvailableNocardioides simplex
UReplication proteinNot AvailablePseudomonas syringae
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism

Hover over products below to view reaction partners

Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AcamprosateThe excretion of Acamprosate can be decreased when combined with Benzoic acid.
AcenocoumarolThe therapeutic efficacy of Acenocoumarol can be increased when used in combination with Benzoic acid.
AcyclovirThe excretion of Acyclovir can be decreased when combined with Benzoic acid.
AllopurinolThe excretion of Allopurinol can be decreased when combined with Benzoic acid.
Aminohippuric acidThe excretion of Aminohippuric acid can be decreased when combined with Benzoic acid.
Food Interactions
No interactions found.

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Product Ingredients
IngredientUNIICASInChI Key
Calcium benzoate3QDE968MKD2090-05-3Not applicable
Sodium benzoateOJ245FE5EU532-32-1WXMKPNITSTVMEF-UHFFFAOYSA-M
Active Moieties
NameKindUNIICASInChI Key
Sodium cationionicLYR4M0NH3717341-25-2FKNQFGJONOIPTF-UHFFFAOYSA-N
Product Images
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Eyelids WipesCloth0.1 g/100gTopicalNingbo Riway Industrial Co., Ltd.2020-09-28Not applicableUS flag
Oriox Cool Breath Oral Rinse MildLiquid0.3 g/100mLTopicalLCC LTD2022-03-25Not applicableUS flag
S Panax All In One MistLiquid0.5 g/100mLTopicalS AND PANAX CO LTD2021-05-18Not applicableUS flag
S Panax MistLiquid0.5 g/100mLTopicalseo jeong ho hwang chill2020-07-24Not applicableUS flag
S Panax Mist for RefillLiquid0.5 g/100mLTopicalseo jeong ho hwang chill2021-03-19Not applicableUS flag
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Acerbine - LösungBenzoic acid (1.5 mg/g) + Malic acid (21.5 mg/g) + Salicylic acid (0.4 mg/g)SolutionTopicalPharmazeutische Fabrik Montavit Gmb H1972-08-28Not applicableAustria flag
Acerbine - SalbeBenzoic acid (0.5 mg/g) + Malic acid (7 mg/g) + Salicylic acid (0.133 mg/g)OintmentTopicalPharmazeutische Fabrik Montavit Gmb H1977-11-17Not applicableAustria flag
AmmonulSodium benzoate (100 mg/1mL) + Sodium phenylacetate (100 mg/1mL)Injection, solution, concentrateIntravenousCangene Bio Pharma2005-02-012010-02-18US flag
AmmonulSodium benzoate (100 mg/1mL) + Sodium phenylacetate (100 mg/1mL)Injection, solution, concentrateIntravenousBausch Health US LLC2005-02-17Not applicableUS flag
AmmonulSodium benzoate (100 mg/1mL) + Sodium phenylacetate (100 mg/1mL)Injection, solution, concentrateIntravenousUcyclyd Pharma Inc.2005-02-17Not applicableUS flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Eyelids WipesBenzoic acid (0.1 g/100g)ClothTopicalNingbo Riway Industrial Co., Ltd.2020-09-28Not applicableUS flag
HydroGold 9Sodium benzoate (0.5 mg/100mg) + Acetyl hexapeptide-3 (0.01 mg/100mg) + Adenosine (0.04 mg/100mg) + Allantoin (0.2 mg/100mg) + Butylene glycol (2 mg/100mg) + Castor oil (0.4 mg/100mg) + Dimethicone (0.01 mg/100mg) + Glycerin (20 mg/100mg) + Gold (0.0001 mg/100mg) + Nicotinamide (2 mg/100mg) + Phenoxyethanol (0.5 mg/100mg) + Potassium chloride (0.01 mg/100mg) + Titanium dioxide (0.43 mg/100mg) + Xanthan gum (0.5 mg/100mg)PatchTopicalBhmbg Global Branding Inc.2018-03-092019-12-31US flag
HyophenBenzoic acid (9 mg/1) + Hyoscyamine sulfate dihydrate (0.12 mg/1) + Methenamine (81.6 mg/1) + Methylene blue trihydrate (10.8 mg/1) + Phenyl salicylate (36.2 mg/1)TabletOralBiocomp Pharma, Inc.2010-09-212023-12-31US flag
HyophenBenzoic acid (9 mg/1) + Hyoscyamine sulfate dihydrate (0.12 mg/1) + Methenamine (81.6 mg/1) + Methylene blue trihydrate (10.8 mg/1) + Phenyl salicylate (36.2 mg/1)TabletOralStar Pharmaceuticals, Llc2010-09-21Not applicableUS flag
MethylphenBenzoic acid (9 mg/1) + Hyoscyamine sulfate dihydrate (.12 mg/1) + Methenamine (81.6 mg/1) + Methylene blue trihydrate (10.8 mg/1) + Phenyl salicylate (36.2 mg/1)TabletOralKylemore Pharmaceuticals, LLC2010-01-132010-01-14US flag

Categories

ATC Codes
A16AX30 — Sodium benzoate and sodium phenylacetateA16AX11 — Sodium benzoateV04CG30 — Caffeine and sodium benzoate
Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as benzoic acids. These are organic Compounds containing a benzene ring which bears at least one carboxyl group.
Kingdom
Organic compounds
Super Class
Benzenoids
Class
Benzene and substituted derivatives
Sub Class
Benzoic acids and derivatives
Direct Parent
Benzoic acids
Alternative Parents
Benzoyl derivatives / Monocarboxylic acids and derivatives / Carboxylic acids / Organooxygen compounds / Organic oxides / Hydrocarbon derivatives
Substituents
Aromatic homomonocyclic compound / Benzoic acid / Benzoyl / Carboxylic acid / Carboxylic acid derivative / Hydrocarbon derivative / Monocarboxylic acid or derivatives / Organic oxide / Organic oxygen compound / Organooxygen compound
Molecular Framework
Aromatic homomonocyclic compounds
External Descriptors
benzoic acids (CHEBI:30746)
Affected organisms
Not Available

Chemical Identifiers

UNII
8SKN0B0MIM
CAS number
65-85-0
InChI Key
WPYMKLBDIGXBTP-UHFFFAOYSA-N
InChI
InChI=1S/C7H6O2/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H,8,9)
IUPAC Name
benzoic acid
SMILES
OC(=O)C1=CC=CC=C1

References

Synthesis Reference

Ludovicus A. L. Kleintjens, Hubertus M. J. Grooten, "Process for the preparation of benzoic acid." U.S. Patent US4539425, issued March, 1932.

US4539425
General References
Not Available
Human Metabolome Database
HMDB0001870
KEGG Drug
D00038
KEGG Compound
C00180
PubChem Compound
243
PubChem Substance
46504911
ChemSpider
238
BindingDB
197302
RxNav
18989
ChEBI
30746
ChEMBL
CHEMBL541
ZINC
ZINC000000001011
PharmGKB
PA448578
PDBe Ligand
BEZ
Wikipedia
Benzoic_acid
PDB Entries
1a8u / 1djr / 1gxs / 1gyx / 1h4o / 1hd2 / 1hkq / 1hz4 / 1i69 / 1i7q
show 192 more

Clinical Trials

Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package
PhaseStatusPurposeConditionsCountStart DateWhy Stopped100+ additional columns
4CompletedTreatmentFungal Foot Infection1somestatusstop reasonjust information to hide
2CompletedOtherSchizoaffective Disorders / Schizophrenia / Schizophreniform Disorders1somestatusstop reasonjust information to hide
2CompletedSupportive CareCancer / Pain1somestatusstop reasonjust information to hide
2CompletedTreatmentAmino Acid Metabolism, Inborn Errors1somestatusstop reasonjust information to hide
2Not Yet RecruitingTreatmentSchizoaffective Disorders / Schizophrenia / Symptoms, Cognitive1somestatusstop reasonjust information to hide

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, solution, concentrateIntravenous
SuspensionOral2.000 g
TinctureOral
SolutionRectal
Paste, dentifriceDental
ClothTopical0.1 g/100g
LotionTopical
PatchTopical
LozengeOral
SolutionTopical
TabletOral
LiquidTopical
Tablet, orally disintegratingOral
Tablet, solubleOral
LiquidTopical0.3 g/100mL
LiquidDental
OintmentCutaneous
OintmentTopical6 % w/w
LiquidTopical0.5 g/100mL
CreamTopical
InjectionIntravenous
LiquidOral
Tablet, coatedOral
OintmentTopical
SyrupOral
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
PropertyValueSource
melting point (°C)122.4 °CPhysProp
boiling point (°C)249.2 °CPhysProp
water solubility3400 mg/L (at 25 °C)YALKOWSKY,SH & DANNENFELSER,RM (1992)
logP1.87HANSCH,C ET AL. (1995)
logS-1.55ADME Research, USCD
pKa4.19 (at 25 °C)LIDE,DR (1996)
Predicted Properties
PropertyValueSource
Water Solubility7.08 mg/mLALOGPS
logP1.72ALOGPS
logP1.63Chemaxon
logS-1.2ALOGPS
pKa (Strongest Acidic)4.08Chemaxon
Physiological Charge-1Chemaxon
Hydrogen Acceptor Count2Chemaxon
Hydrogen Donor Count1Chemaxon
Polar Surface Area37.3 Å2Chemaxon
Rotatable Bond Count1Chemaxon
Refractivity33.31 m3·mol-1Chemaxon
Polarizability11.97 Å3Chemaxon
Number of Rings1Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleYesChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.9886
Blood Brain Barrier+0.9557
Caco-2 permeable+0.9187
P-glycoprotein substrateNon-substrate0.8494
P-glycoprotein inhibitor INon-inhibitor0.9914
P-glycoprotein inhibitor IINon-inhibitor0.9941
Renal organic cation transporterNon-inhibitor0.9136
CYP450 2C9 substrateNon-substrate0.8003
CYP450 2D6 substrateNon-substrate0.9672
CYP450 3A4 substrateNon-substrate0.8374
CYP450 1A2 substrateNon-inhibitor0.8532
CYP450 2C9 inhibitorNon-inhibitor0.9861
CYP450 2D6 inhibitorNon-inhibitor0.957
CYP450 2C19 inhibitorNon-inhibitor0.9878
CYP450 3A4 inhibitorNon-inhibitor0.9822
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9863
Ames testNon AMES toxic0.9923
CarcinogenicityNon-carcinogens0.6024
BiodegradationReady biodegradable0.8983
Rat acute toxicity1.7896 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9708
hERG inhibition (predictor II)Non-inhibitor0.9882
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
GC-MS Spectrum - GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies)GC-MSsplash10-0a70-0900000000-5284a0c1c77a1979e1f4
GC-MS Spectrum - GC-MS (1 TMS)GC-MSsplash10-056r-3900000000-1c74c32fa650fcd4cb4d
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-0kmi-7900000000-5ad752bd6787261a11d0
GC-MS Spectrum - EI-BGC-MSsplash10-05i0-6900000000-fa50606b2e84fc4cefe9
GC-MS Spectrum - EI-BGC-MSsplash10-0a6r-9600000000-d08dbc757a6de6c3f54e
GC-MS Spectrum - EI-BGC-MSsplash10-0adi-9800000000-40f904bf20072c72a08b
GC-MS Spectrum - EI-BGC-MSsplash10-0pk9-9800000000-b93fc1120a1c74b88fa3
GC-MS Spectrum - EI-BGC-MSsplash10-05i0-5900000000-1b6bbf98557af374f3a5
GC-MS Spectrum - EI-BGC-MSsplash10-0570-0900000000-ecd208f1e7b4d5ad85f2
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-0a70-0900000000-5284a0c1c77a1979e1f4
GC-MS Spectrum - GC-MSGC-MSsplash10-056r-3900000000-1c74c32fa650fcd4cb4d
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-0a70-0900000000-cec9e1ab69521049d1e4
Mass Spectrum (Electron Ionization)MSsplash10-0pk9-8900000000-3d79c70c455799ab33e3
MS/MS Spectrum - Quattro_QQQ 10V, Positive (Annotated)LC-MS/MSsplash10-00b9-9500000000-f312a552bef1a2927e64
MS/MS Spectrum - Quattro_QQQ 25V, Positive (Annotated)LC-MS/MSsplash10-004i-9100000000-dafd91c9134bc4143743
MS/MS Spectrum - Quattro_QQQ 40V, Positive (Annotated)LC-MS/MSsplash10-00b9-9400000000-29ca905567aa5c59d46b
MS/MS Spectrum - EI-B (HITACHI RMU-7) , PositiveLC-MS/MSsplash10-05i0-6900000000-fa50606b2e84fc4cefe9
MS/MS Spectrum - EI-B (HITACHI RMU-6E) , PositiveLC-MS/MSsplash10-0a6r-9600000000-d08dbc757a6de6c3f54e
MS/MS Spectrum - EI-B (HITACHI RMU-7M) , PositiveLC-MS/MSsplash10-0adi-9800000000-2693809ae064e720bf58
MS/MS Spectrum - EI-B (HITACHI M-80B) , PositiveLC-MS/MSsplash10-0pk9-9800000000-2c6be5ecee1848091a24
LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 10V, NegativeLC-MS/MSsplash10-00di-0900000000-4644ee08861e75d0b808
LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 20V, NegativeLC-MS/MSsplash10-00b9-9400000000-11baabb3c0bb283b1c6e
LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 30V, NegativeLC-MS/MSsplash10-004l-9100000000-4875643627420279223b
LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 40V, NegativeLC-MS/MSsplash10-0006-9000000000-97a21f3206f5c1f0ba7e
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-00di-0900000000-4644ee08861e75d0b808
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-00b9-9400000000-11baabb3c0bb283b1c6e
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-004l-9100000000-4875643627420279223b
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-0006-9000000000-97a21f3206f5c1f0ba7e
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0a6r-7900000000-d1e1e7b66d13731a9346
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-00b9-9700000000-c0485db8f57a76022ca2
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-056r-9700000000-e99c6d9918e8a8f08277
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-004i-9100000000-533f0e08164be6a8cc50
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0zi0-9300000000-dffbcd0c5674fc0d46c0
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-004i-9000000000-b33ea96d3cf5f19da035
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0a6r-7900000000-d1e1e7b66d13731a9346
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-00b9-9700000000-c0485db8f57a76022ca2
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-056r-9700000000-e99c6d9918e8a8f08277
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-004i-9100000000-533f0e08164be6a8cc50
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0zi0-9300000000-dffbcd0c5674fc0d46c0
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-004i-9000000000-b33ea96d3cf5f19da035
1H NMR Spectrum1D NMRNot Applicable
1H NMR Spectrum1D NMRNot Applicable
13C NMR Spectrum1D NMRNot Applicable
1H NMR Spectrum1D NMRNot Applicable
13C NMR Spectrum1D NMRNot Applicable
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
[1H,1H] 2D NMR Spectrum2D NMRNot Applicable
[1H,13C] 2D NMR Spectrum2D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-121.4804474
predicted
DarkChem Lite v0.1.0
[M-H]-126.0665922
predicted
DarkChem Standard v0.1.0
[M-H]-121.2776474
predicted
DarkChem Lite v0.1.0
[M-H]-120.1701
predicted
DeepCCS 1.0 (2019)
[M-H]-121.4804474
predicted
DarkChem Lite v0.1.0
[M-H]-126.0665922
predicted
DarkChem Standard v0.1.0
[M-H]-121.2776474
predicted
DarkChem Lite v0.1.0
[M-H]-120.1701
predicted
DeepCCS 1.0 (2019)
[M+H]+123.370995
predicted
DeepCCS 1.0 (2019)
[M+H]+123.370995
predicted
DeepCCS 1.0 (2019)
[M+Na]+132.1631
predicted
DeepCCS 1.0 (2019)
[M+Na]+132.1631
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
General Function
Proton-dependent oligopeptide secondary active transmembrane transporter activity
Specific Function
Proton-coupled intake of oligopeptides of 2 to 4 amino acids with a preference for dipeptides. May constitute a major route for the absorption of protein digestion end-products.
Gene Name
SLC15A1
Uniprot ID
P46059
Uniprot Name
Solute carrier family 15 member 1
Molecular Weight
78805.265 Da
References
  1. Omkvist DH, Trangbaek DJ, Mildon J, Paine JS, Brodin B, Begtrup M, Nielsen CU: Affinity and translocation relationships via hPEPT1 of H-X aa-Ser-OH dipeptides: evaluation of H-Phe-Ser-OH as a pro-moiety for ibuprofen and benzoic acid prodrugs. Eur J Pharm Biopharm. 2011 Feb;77(2):327-31. doi: 10.1016/j.ejpb.2010.12.009. Epub 2010 Dec 13. [Article]
Kind
Protein
Organism
Rhodococcus sp. (strain MB1 Bresler)
Pharmacological action
Unknown
Actions
Product of
General Function
Dipeptidyl-peptidase activity
Specific Function
Hydrolyzes cocaine to benzoate and ecgonine methyl ester, endowing the bacteria with the ability to utilize cocaine as a sole source of carbon and energy for growth, as this bacterium lives in the ...
Gene Name
cocE
Uniprot ID
Q9L9D7
Uniprot Name
Cocaine esterase
Molecular Weight
62131.125 Da
References
  1. Bresler MM, Rosser SJ, Basran A, Bruce NC: Gene cloning and nucleotide sequencing and properties of a cocaine esterase from Rhodococcus sp. strain MB1. Appl Environ Microbiol. 2000 Mar;66(3):904-8. [Article]
  2. Lister DL, Sproule RF, Britt AJ, Lowe CR, Bruce NC: Degradation of cocaine by a mixed culture of Pseudomonas fluorescens MBER and Comamonas acidovorans MBLF. Appl Environ Microbiol. 1996 Jan;62(1):94-9. [Article]
Details
3. D-amino-acid oxidase
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
General Function
Receptor binding
Specific Function
Regulates the level of the neuromodulator D-serine in the brain. Has high activity towards D-DOPA and contributes to dopamine synthesis. Could act as a detoxifying agent which removes D-amino acids...
Gene Name
DAO
Uniprot ID
P14920
Uniprot Name
D-amino-acid oxidase
Molecular Weight
39473.75 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]
  3. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
Kind
Protein
Organism
Rhodococcus opacus
Pharmacological action
Unknown
Actions
Substrate
Curator comments
Literature referenced utilizes Stenotrophomonas maltophilia as their organism.
General Function
Ferric iron binding
Specific Function
Not Available
Gene Name
clcA
Uniprot ID
O67987
Uniprot Name
Chlorocatechol 1,2-dioxygenase
Molecular Weight
28952.3 Da
References
  1. Guzik U, Hupert-Kocurek K, Sitnik M, Wojcieszynska D: High activity catechol 1,2-dioxygenase from Stenotrophomonas maltophilia strain KB2 as a useful tool in cis,cis-muconic acid production. Antonie Van Leeuwenhoek. 2013 Jun;103(6):1297-307. doi: 10.1007/s10482-013-9910-8. Epub 2013 Mar 28. [Article]
Kind
Protein
Organism
Pseudomonas fluorescens
Pharmacological action
Unknown
General Function
Hydrolase activity
Specific Function
Not Available
Gene Name
cumD
Uniprot ID
P96965
Uniprot Name
2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase
Molecular Weight
31489.385 Da
Kind
Protein
Organism
Streptomyces aureofaciens
Pharmacological action
Unknown
General Function
Chloride peroxidase activity
Specific Function
Not Available
Gene Name
cpo
Uniprot ID
O31168
Uniprot Name
Non-heme chloroperoxidase
Molecular Weight
30354.465 Da
Kind
Protein
Organism
Enterobacter cloacae
Pharmacological action
Unknown
General Function
Oxidoreductase activity
Specific Function
Reduction of a variety of nitroaromatic compounds using NADH (and to lesser extent NADPH) as source of reducing equivalents; two electrons are transferred.
Gene Name
nfsB
Uniprot ID
Q01234
Uniprot Name
Oxygen-insensitive NAD(P)H nitroreductase
Molecular Weight
23949.98 Da
Kind
Protein
Organism
Nocardioides simplex
Pharmacological action
Unknown
General Function
Hydroxyquinol 1,2-dioxygenase activity
Specific Function
Catalyzes the ortho-cleavage of the aromatic ring of hydroxyquinol.
Gene Name
chqB
Uniprot ID
Q5PXQ6
Uniprot Name
Hydroxyquinol 1,2-dioxygenase
Molecular Weight
31966.33 Da
Kind
Protein
Organism
Pseudomonas syringae
Pharmacological action
Unknown
General Function
Dna-directed dna polymerase activity
Specific Function
Not Available
Gene Name
repA
Uniprot ID
Q52546
Uniprot Name
Replication protein
Molecular Weight
26728.84 Da

Transporters

Kind
Protein
Organism
Humans
Pharmacological action
Unknown
Actions
Inhibitor
General Function
Sodium-independent organic anion transmembrane transporter activity
Specific Function
Mediates the Na(+)-independent transport of organic anions such as taurocholate, the prostaglandins PGD2, PGE1, PGE2, leukotriene C4, thromboxane B2 and iloprost.
Gene Name
SLCO2B1
Uniprot ID
O94956
Uniprot Name
Solute carrier organic anion transporter family member 2B1
Molecular Weight
76709.98 Da
References
  1. Kobayashi D, Nozawa T, Imai K, Nezu J, Tsuji A, Tamai I: Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane. J Pharmacol Exp Ther. 2003 Aug;306(2):703-8. Epub 2003 Apr 30. [Article]
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
Actions
Inhibitor
General Function
Sodium-independent organic anion transmembrane transporter activity
Specific Function
Plays an important role in the excretion/detoxification of endogenous and exogenous organic anions, especially from the brain and kidney. Involved in the transport basolateral of steviol, fexofenad...
Gene Name
SLC22A8
Uniprot ID
Q8TCC7
Uniprot Name
Solute carrier family 22 member 8
Molecular Weight
59855.585 Da
References
  1. Ohtsuki S, Asaba H, Takanaga H, Deguchi T, Hosoya K, Otagiri M, Terasaki T: Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain. J Neurochem. 2002 Oct;83(1):57-66. [Article]
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
General Function
Symporter activity
Specific Function
Proton-coupled monocarboxylate transporter. Catalyzes the rapid transport across the plasma membrane of many monocarboxylates such as lactate, pyruvate, branched-chain oxo acids derived from leucin...
Gene Name
SLC16A1
Uniprot ID
P53985
Uniprot Name
Monocarboxylate transporter 1
Molecular Weight
53943.685 Da
References
  1. Kido Y, Tamai I, Okamoto M, Suzuki F, Tsuji A: Functional clarification of MCT1-mediated transport of monocarboxylic acids at the blood-brain barrier using in vitro cultured cells and in vivo BUI studies. Pharm Res. 2000 Jan;17(1):55-62. [Article]

Drug created at June 13, 2005 13:24 / Updated at June 02, 2024 21:55